Example of the targeted action of a meganuclease for site-directed gene insertion at a specific locus Photo: Cellectis

Bayer CropScience and the French genomics company, Cellectis (Paris), are using Meganuclease technology to develop new crops.  

The Meganucleases, a proprietary genome engineering technology developed by Cellectis, allow precise “editing” of genetic sequences by binding and cutting at a single point in a chosen genome. ”This new programme comforts our presence in the agrobiotech field,” says David Sourdice, vice-president of corporate development at Cellectis. Cellectis and Bayer have been collaborating together since 2006.
By Simon Varcoe

> Not a subscriber? Subscribe

MORE NEWS ON BIOTECHNOLOGY

DuPont and Evogene in drought tolerance collaboration
BASF to develop nutritional oil crops
BASF’s GM blight-resistant potatoes
Monsanto trials drought-resistant maize
Bayer & Cellectis collaborate on gene technology